
APOE Christchurch Mutation Blocks Parkinson's Proteins in Lab Models
A rare genetic variant known as the Christchurch mutation prevents the accumulation of toxic proteins linked to Parkinson's disease and Lewy body dementia, according to mouse experiments at Oregon Health & Science University. The biomedical innovation, published in Cell Reports, points to a potential gene therapy approach that could shield both motor and cognitive brain functions from neurodegenerative decline.







